Rasagiline 1 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily, as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If well tolerated but the clinical response is insufficient, the dose may be increased to 1 mg once daily. This medicine may be taken with or without food.

This medication should not be administered to certain patients. If there is an allergy to this drug's active ingredient or any other ingredients, it should not be taken. Moreover, this medication should not be used if currently taking or if stopped taking other MAO inhibitors within the past 2 weeks. It should also be avoided if taking certain medications such as pethidine, tramadol, or dextromethorphan, or if stopped taking them within 2 weeks. Patients with moderate to severe liver dysfunction may also face risks from this medication. During the course of treatment, various side effects may occur. Headaches, dizziness, dermatitis, nausea, insomnia, and arthralgia are commonly reported symptoms. Additionally, psychiatric symptoms such as hallucinations or depression may arise. Serious side effects such as movement disorders, blood pressure fluctuations, and impulse control issues may also occur, necessitating regular monitoring. This medication has a high potential for drug interactions. In particular, serious side effects can occur when used in combination with other MAO inhibitors, certain pain relievers, antidepressants, cold medications, or sympathomimetics, so it is crucial to consult a doctor. Also, caution should be exercised regarding changes in drug concentration when taken with medications affecting the CYP1A2 enzyme. Use during pregnancy or lactation should be approached with caution. The safety and efficacy in children under 18 years have not been established, while individuals over 65 years can use it without special dose adjustment. In cases of overdose, severe symptoms such as mild manic episodes, hypertensive crises, and serotonin syndrome may develop, so if overdose is suspected, immediate medical assistance is required. This medication should be kept out of reach of children and stored at a temperature between 1°C and 25°C. It is advisable to avoid transferring to another container to maintain quality.

• Influenza
• skin cancer
• leukopenia
• allergy
• appetite loss
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication can be sensitive to air and humidity, hence it should be stored in a tightly sealed container. It is also best to keep it at room temperature, which is not too hot or too cold, specifically between 1°C and 25°C.

Appearance

Flat round tablet with edges that are white or nearly white

Package unit

30 tablets/bottle